NCT00410735View on ClinicalTrials.gov

Study of ONO-1078 in Patients With Chronic Sinusitis

PHASE3CompletedINTERVENTIONAL
Enrollment

495

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

June 30, 2008

Conditions
Chronic Sinusitis
Interventions
DRUG

Placebo

0 mg BID for 12 weeks

DRUG

Pranlukast hydrate

225 mg BID for 12 weeks

Trial Locations (6)

Unknown

Chubu region, Chūbu

Hokuriku region, Hokuriku

Kanto region, Kanto

Kinki region, Kinki

Kyushu region, Kyushu

Tohoku region, Tōhoku

Sponsors
All Listed Sponsors
lead

Ono Pharmaceutical Co. Ltd

INDUSTRY

NCT00410735 - Study of ONO-1078 in Patients With Chronic Sinusitis | Biotech Hunter | Biotech Hunter